{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:53:50Z","timestamp":1790967230588,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.pharma.2011.11.002","type":"journal-article","created":{"date-parts":[[2011,12,16]],"date-time":"2011-12-16T19:25:05Z","timestamp":1324063505000},"page":"26-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Applications de l\u2019imagerie pour l\u2019\u00e9tude de la biodistribution et du m\u00e9tabolisme de nouvelles mol\u00e9cules"],"prefix":"10.1016","volume":"70","author":[{"given":"C.","family":"Corot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-M.","family":"Id\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-S.","family":"Raynaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-F.","family":"Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Catoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.pharma.2011.11.002_bib0005","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.crad.2010.03.011","article-title":"Molecular imaging: current status and emerging strategies","volume":"65","author":"Pysz","year":"2010","journal-title":"Clin Radiol"},{"issue":"7187","key":"10.1016\/j.pharma.2011.11.002_bib0010","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nature06917","article-title":"Imaging in the era of molecular oncology","volume":"452","author":"Weissleder","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.pharma.2011.11.002_bib0015","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0399-8320(05)80773-0","article-title":"L\u2019endoscopie confocale","volume":"29","author":"Mordon","year":"2005","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.pharma.2011.11.002_bib0020","unstructured":"Concept Paper sur l\u2019imagerie en toxicologie. Direction de l\u2019\u00e9valuation des m\u00e9dicaments et des produits biologiques Afssaps. 30\u00a0juillet 2009. http:\/\/www.afssaps.fr."},{"key":"10.1016\/j.pharma.2011.11.002_bib0025","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/CIRCULATIONAHA.109.916338","article-title":"Cardiovascular molecular imaging. Focus on clinical translation","volume":"123","author":"Chen","year":"2011","journal-title":"Circ"},{"issue":"11","key":"10.1016\/j.pharma.2011.11.002_bib0030","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.addr.2010.08.009","article-title":"Imaging of cellular therapies","volume":"62","author":"Srinivas","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.pharma.2011.11.002_bib0035","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrd2027","article-title":"A role for fMRI in optimizing CNS drug development","volume":"5","author":"Borsook","year":"2006","journal-title":"Nature Rev Drug Discov"},{"key":"10.1016\/j.pharma.2011.11.002_bib0040","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1053\/j.semnuclmed.2011.02.005","article-title":"Positron emission tomography radiopharmaceuticals for imaging brain beta-Amyloid","volume":"41","author":"Vallabhajosula","year":"2011","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.pharma.2011.11.002_bib0045","unstructured":"Guidance for industry: developing medical imaging drug and biological products. Part 1: Clinical indications. June 2004 http:\/\/www.fda.gov."},{"key":"10.1016\/j.pharma.2011.11.002_bib0050","unstructured":"Guideline on clinical evaluation of diagnostic agents. Committee for medicinal products for human use (CHMP). 23\u00a0July 2009\u00a0EMA; http:\/\/www.ema.europa."},{"issue":"1","key":"10.1016\/j.pharma.2011.11.002_bib0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/157489011794578446","article-title":"Ultrasound microbubble contrast and current clinical applications","volume":"6","author":"Dindyal","year":"2011","journal-title":"Recent Patents Cardiovasc Drug Discov"},{"issue":"14","key":"10.1016\/j.pharma.2011.11.002_bib0060","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.addr.2006.09.013","article-title":"Recent advances in iron oxide nanocrystal technology for medical imaging","volume":"58","author":"Corot","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"10.1016\/j.pharma.2011.11.002_bib0065","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1021\/mp100228v","article-title":"Nanotheranostics and image-guided drug delivery: current concepts and future directions","volume":"7","author":"Lammers","year":"2010","journal-title":"Mol Pharm"},{"key":"10.1016\/j.pharma.2011.11.002_bib0070","first-page":"165","article-title":"Les limites du SUV","volume":"31","author":"Buvat","year":"2007","journal-title":"Med Nucl"},{"key":"10.1016\/j.pharma.2011.11.002_bib0075","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/nbm.1098","article-title":"Prediction of chemotherapeutic response of colorectal liver metastases with dynamic gadolinium-DTPA-enhanced MRI and localized 19F MRS pharmacokinetic studies of 5-fluorouracil","volume":"20","author":"van Laarhoven","year":"2007","journal-title":"NMR Biomed"},{"issue":"25","key":"10.1016\/j.pharma.2011.11.002_bib0080","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1523\/JNEUROSCI.1792-04.2005","article-title":"Catechol-O-methyltransferase val158met genotype affects. processing of emotional stimuli in the amygdala and prefrontal cortex","volume":"26","author":"Smolka","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharma.2011.11.002_bib0085","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1021\/cr9004007","article-title":"Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnostic in cancer","volume":"110","author":"Glunde","year":"2010","journal-title":"Chem Rev"},{"key":"10.1016\/j.pharma.2011.11.002_bib0090","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharma.2011.11.002_bib0095","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1053\/j.semnuclmed.2011.02.002","article-title":"The next generation of positron emission topography radiopharmaceuticals in oncology","volume":"41","author":"Rice","year":"2011","journal-title":"Seminar Nucl Med"},{"key":"10.1016\/j.pharma.2011.11.002_bib0100","first-page":"144","article-title":"Hallmarks of cancer: the next generation","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.pharma.2011.11.002_bib0105","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s00259-010-1569-z","article-title":"Chen. Molecular Imaging in cancer treatment","volume":"38","author":"Michalski","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"suppl 1","key":"10.1016\/j.pharma.2011.11.002_bib0110","doi-asserted-by":"crossref","first-page":"106S","DOI":"10.2967\/jnumed.108.057281","article-title":"Radiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PET","volume":"50","author":"Dunphy","year":"2009","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.pharma.2011.11.002_bib0115","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/157340507780619179","article-title":"Dynamic contrast enhanced magnetic resonance imaging in oncology: theory, data acquisition, analysis and examples","volume":"3","author":"Yankeelov","year":"2009","journal-title":"Curr Med Imaging Rev"},{"key":"10.1016\/j.pharma.2011.11.002_bib0120","series-title":"Methods in molecular biology. Angiogenesis protocols (Second edition)","first-page":"25","article-title":"Imaging angiogenesis","author":"Charnley","year":"2009"},{"key":"10.1016\/j.pharma.2011.11.002_bib0125","doi-asserted-by":"crossref","first-page":"19801","DOI":"10.1073\/pnas.0911447106","article-title":"Production of hyperpolarized [1,4-13C2]malate from [1,4-13C2]fumarate is a marker of cell necrosis and treatment response in tumors","volume":"106","author":"Gallagher","year":"2009","journal-title":"PNAS USA"},{"key":"10.1016\/j.pharma.2011.11.002_bib0130","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2967\/jnumed.109.065706","article-title":"Of mice and humans: are they the same? Implications in cancer translational research","volume":"51","author":"de Jong","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pharma.2011.11.002_bib0135","unstructured":"International Conference on Harmonization. Guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals ICH M3(R2), step 4, 11\u00a0June 2009."},{"issue":"2","key":"10.1016\/j.pharma.2011.11.002_bib0140","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10456-010-9165-1","article-title":"Paramagnetic and fluorescent liposomes for target-specific imaging and therapy of tumor angiogenesis","volume":"13","author":"Strijkers","year":"2010","journal-title":"Angiogenesis"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000345091100157X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000345091100157X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T23:29:48Z","timestamp":1757719788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000345091100157X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S000345091100157X"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2011.11.002","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Applications de l\u2019imagerie pour l\u2019\u00e9tude de la biodistribution et du m\u00e9tabolisme de nouvelles mol\u00e9cules","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2011.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}